Abstract:Background: The induction of protective T cell responses requires two signals: Signal 1 is generated by activation of the T cell receptor (TCR) and signal 2 results from ligation of the CD28 molecule. Costimulation of the TCR and CD28 is necessary, as the TCR is very good at discriminating between endogenous and foreign structures (antigens), but not all foreign antigens (such as food antigens) are dangerous to the body. A strong CD28 signal, thus, indicates to the T cell that there is indeed a threat and that an immune response is urgently required. However, to avoid autoimmunity and excessive immune responses, further regulatory circuits, provided by immune checkpoints, are necessary. Objectives: To provide an introduction to immunoregulation mediated by checkpoint molecules. Materials and methods: Review of basic science papers and reports on clinical studies. Results: The most prominent and best characterized checkpoint molecules, cytotoxic T lymphocyte-associated protein‑4 (CTLA-4) and programmed cell death‑1 (PD-1), both physiologically dampen CD28-mediated costimulation. Pathologically, malignancies exploit the immunoregulatory function of checkpoint molecules by, for example, expressing ligands for PD‑1 on the cell surface, thus, avoiding being attacked by T cells. Our understanding of these negative feedback regulations has led to the development of checkpoint inhibitors, which have already become part of routine clinical care of cancer patients. Conclusions: Due to the clinical success of checkpoint inhibitors, the concept of cancer immunotherapy has received a massive boost and hopes are high that many more clinical advancements in cancer therapy can be achieved with novel forms of immunotherapy.

CD28 co-receptor signal transduction in T-cell activation

CD28 Costimulation: From Mechanism to Therapy

T Cell Costimulation through CD28 Depends on Induction of the Bcl-xγ Isoform

CD28 Shapes T Cell Receptor Signaling by Regulating ZAP70 Activation and Lck Dynamics

T cell costimulation through CD28 depends on induction of the Bcl-xgamma isoform: analysis of Bcl-xgamma-deficient mice.

The Role of the CD28 Family Receptors in T-Cell Immunomodulation

Dynamic Regulation of CD28 Conformation and Signaling by Charged Lipids and Ions

CD28 Individual Signaling Up-regulates Human IL-17A Expression by Promoting the Recruitment of RelA/NF-κB and STAT3 Transcription Factors on the Proximal Promoter

CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro

Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion

CD28 costimulation is essential for human T regulatory expansion and function

CD28 co-stimulation: novel insights and applications in cancer immunotherapy

Cis Interactions Between CD2 and Its Ligands on T Cells Are Required for T Cell Activation

Cd28-Mediated Signaling In-Vivo Prevents Activation-Induced Apoptosis In The Thymus And Alters Peripheral Lymphocyte Homeostasis

CD28 Signal Enhances Apoptosis of CD8 T Cells after Strong TCR Ligation

Cd28 Costimulation Inhibits Tcr-Induced Apoptosis During A Primary T Cell Response

Molecular Dynamics of Co-signal Molecules in T-Cell Activation

CD28 engagement inhibits CD73-mediated regulatory activity of CD8+ T cells

[CD28 costimulation and checkpoint inhibition in T cells]

Recurrent activating mutations of CD28 in peripheral T-cell lymphomas

CD28-mediated regulation of multiple myeloma cell proliferation and survival